Other exchanges or trading platforms where Scancell Holdings plc securities are admitted or traded:

Scancell Holdings securities are listed on AIM, and the latest share price is shown here

The number of securities in issue:

The company has an issued share capital of 465,355,867 ordinary shares of 0.1p each, all of which are called up and fully paid.

Pursuant to the License and Supply Agreement (‘the Agreement’) dated 13 July 2009, the Company has granted options over 3,184,630 ordinary shares to ICHOR at 4.5p per share.

Directors’ Share Options:

The Company has granted the following options to Directors of the Company. 

Option holder Option price per ordinary share Number of ordinary shares under option Last day of exercise period
Sally Adams 10.5p 2,500,000 30 January 2028
John Chiplin 17.0p 3,000,000 18 April 2026
Lindy Durrant 4.5p 3,850,000 14 July 2020
Lindy Durrant 10.5p 9,000,000 30 January 2028
Richard Goodfellow 4.5p 2,880,000 14 July 2020
Richard Goodfellow 33.2p 3,500,000 31 December 2023
Clifford Holloway 10.5p 3,000,000 30 January 2028


In addition to the above, the Company has granted options over 1,396,016 shares of the Company to various other persons at exercise prices between 5p and 33.2p.

Percentage of AIM securities not in public hands:

As at 31 December 2019 the percentage of AIM securities not in public hands was: 32.14%

Restrictions on the transfer of securities:

There are no restrictions on the transfer of shares.

Identity and percentage holdings of significant shareholders:

As at 31 December 2019 the identity and percentage holdings of significant shareholders were: 

  Ordinary shares at 0.1p each
  Number Percentage
Vulpes Life Science Fund 80,549,311 17.31%
Calculus Capital 49,844,165 10.71%
Scancell Holdings plc directors and related holdings 19,163,147 4.12%